B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Royalactin

8 PubMed studies analyzed · Evidence Score: 26.2

Research Domains

Royalactin has been studied across 3 research domains including ⏳ Longevity & Aging, ♀♂ Sexual Health, 🫘 Kidney. The primary research focus is ⏳ Longevity & Aging with 38% of studies addressing this area.

Loading evidence profile...

This evidence profile for Royalactin is generated deterministically from 8 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.